1 Result(s)

Article

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

The HER2-enriched (HER2-E) subtype within HER2-positive (HER2+) breast cancer is highly addicted to the HER2 pathway. However, ∼20–60% of HER2+/HER2-E tumors do not achieve a complete response following anti-H...

Fara Brasó-Maristany, Gaia Griguolo, Tomás Pascual, Laia Paré… in Nature Communications (2020)